| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial MD Tameris, M Hatherill, BS Landry, TJ Scriba, MA Snowden, S Lockhart, ... The Lancet 381 (9871), 1021-1028, 2013 | 1052 | 2013 |
| A blood RNA signature for tuberculosis disease risk: a prospective cohort study DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ... The Lancet 387 (10035), 2312-2322, 2016 | 629 | 2016 |
| Identifying specificity groups in the T cell receptor repertoire J Glanville, H Huang, A Nau, O Hatton, LE Wagar, F Rubelt, X Ji, A Han, ... Nature 547 (7661), 94-98, 2017 | 588 | 2017 |
| Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011 | 579 | 2011 |
| Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response TJ Scriba, B Kalsdorf, DA Abrahams, F Isaacs, J Hofmeister, G Black, ... The Journal of Immunology 180 (3), 1962-1970, 2008 | 506 | 2008 |
| Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns BMN Kagina, B Abel, TJ Scriba, EJ Hughes, A Keyser, A Soares, ... American journal of respiratory and critical care medicine 182 (8), 1073-1079, 2010 | 462 | 2010 |
| Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination E Nemes, H Geldenhuys, V Rozot, KT Rutkowski, F Ratangee, N Bilek, ... New England Journal of Medicine 379 (2), 138-149, 2018 | 442 | 2018 |
| T cells and adaptive immunity to Mycobacterium tuberculosis in humans LD Jasenosky, TJ Scriba, WA Hanekom, AE Goldfeld Immunological reviews 264 (1), 74-87, 2015 | 302 | 2015 |
| Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ... New England Journal of Medicine 379 (17), 1621-1634, 2018 | 297 | 2018 |
| Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles AP Soares, TJ Scriba, S Joseph, R Harbacheuski, RA Murray, ... The Journal of Immunology 180 (5), 3569-3577, 2008 | 275 | 2008 |
| Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells LJ Walker, YH Kang, MO Smith, H Tharmalingham, N Ramamurthy, ... Blood, The Journal of the American Society of Hematology 119 (2), 422-433, 2012 | 256 | 2012 |
| T-cell activation is an immune correlate of risk in BCG vaccinated infants HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ... Nature communications 7 (1), 1-11, 2016 | 252 | 2016 |
| Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells TJ Scriba, M Tameris, N Mansoor, E Smit, L van der Merwe, F Isaacs, ... European journal of immunology 40 (1), 279-290, 2010 | 250 | 2010 |
| Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ... New England Journal of Medicine 381 (25), 2429-2439, 2019 | 243 | 2019 |
| COMPASS identifies T-cell subsets correlated with clinical outcomes L Lin, G Finak, K Ushey, C Seshadri, TR Hawn, N Frahm, TJ Scriba, ... Nature biotechnology 33 (6), 610-616, 2015 | 214 | 2015 |
| Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa T Hawkridge, TJ Scriba, S Gelderbloem, E Smit, M Tameris, S Moyo, ... The Journal of infectious diseases 198 (4), 544-552, 2008 | 211 | 2008 |
| Four-gene pan-African blood signature predicts progression to tuberculosis S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ... American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018 | 196 | 2018 |
| Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis E Petruccioli, TJ Scriba, L Petrone, M Hatherill, DM Cirillo, SA Joosten, ... European Respiratory Journal 48 (6), 1751-1763, 2016 | 184 | 2016 |
| First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults AKK Luabeya, BMN Kagina, MD Tameris, H Geldenhuys, ST Hoff, Z Shi, ... Vaccine 33 (33), 4130-4140, 2015 | 173 | 2015 |
| Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation A Soares, L Govender, J Hughes, W Mavakla, M de Kock, C Barnard, ... Journal of immunological methods 362 (1-2), 43-50, 2010 | 171 | 2010 |
Willem HanekomAfrica Health Research InstituteVerified email at ahri.org
